LncRNA LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway

被引:113
作者
Cheng, Bo [1 ]
Rong, Aimei [2 ]
Zhou, Quanbo [3 ]
Li, Wenlu [4 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Emergency Surg, 1 Jianshe East Rd, Zhengzhou 410008, Henan, Peoples R China
[2] Zhengzhou Univ, Zhengzhou Cent Hosp, Dept Gastroenterol, Zhengzhou 45000, Henan, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Anus & Intestine Surg, Zhengzhou 45000, Henan, Peoples R China
[4] Zhengzhou Univ, Affiliated Hosp 1, Dept Stomatol, Zhengzhou 45000, Henan, Peoples R China
关键词
LncRNA LINC00662; Colon cancer; miR-340-5p; CLDN8; IL22; Growth; Metastasis; CELL-PROLIFERATION; MIGRATION; INVASION; CHEMOTHERAPY; EXPRESSION;
D O I
10.1186/s13046-019-1510-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background LncRNA LINC00662 is closely related to the occurrence and development of cancer. This study aims to explore the effect of LINC00662 on colon cancer tumor growth and metastasis and its molecular mechanism. Methods CCK8, colony formation, transwell, scratch wound, TUNEL, flow cytometry, RT-PCR, western blotting and immunohistochemistry assays were used to detect the proliferation, apoptosis, invasion and migration of colon cancer cell and mRNA and protein expressions. Luciferase reporter and RNA pull down assays were used to detect the combination of LINC00662 and miR-340-5p or IL22 and the combination of miR-340-5p and CLDN8/IL22. Co-immunoprecipitation were used to detect the co-expression of CLDN8 and IL22 in colon cell lines. The targets of LINC00662 were predicated by Starbase v2.0. The target genes of miR-340-5p were predicated by miRDB and TargetScan. GO and KEGG enrichment analysis were performed by DAVID website. Results LINC00662 was up-regulation in colon cancer tissues and cell lines. Univariate Cox regression analysis showed that the LINC00662 expression level was related to the poor prognosis. LINC00662-WT and miR-340-5p mimics co-transfection depressed luciferase activity and IL22/CLDN8-WT and miR-340-5p inhibitors co-transfection memorably motivated luciferase activity. LINC00662 overexpression promoted cell proliferation, invasion and migration, and inhibited cell apoptosis in colon cancer. In vivo xenograft studies in nude mice manifested that LINC00662 overexpression prominently accelerate tumor growth. There was an opposite reaction in the biological functions of colon cells and tumor growth between LINC00662 overexpression and LINC00662 inhibition in vitro and in vivo. The functions of miR-340-5p mimics regulating the biological functions of colon cells and tumor growth were consistent with those of LINC00662 inhibition. CLDN8 and IL22, as target genes of miR-340-5p, reversed the functions of LINC00662 affecting the biological functions of colon cells and the protein levels of Bax, Bcl-2, XIAP, VEGF, MMP-2, E-cadherin and N-cadherin. Co-immunoprecipitation experiments indicated that CLDN8 directly interact with IL22 in colon cell lines. LINC00662 regulated CLDN8 and IL22 expressions and the activation of ERK signaling pathway via targeting miR-340-5p. Conclusion LINC00662 overexpression promoted the occurrence and development of colon cancer by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway.
引用
收藏
页数:21
相关论文
共 30 条
[1]   High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma [J].
Abudureheman, Abulajiang ;
Ainiwaer, Julaiti ;
Hou, Zhichao ;
Niyaz, Madiniyat ;
Turghun, Abdugheni ;
Hasim, Ayshamgul ;
Zhang, Haiping ;
Lu, Xiaomei ;
Sheyhidin, Ilyar .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (06) :1025-1035
[2]   Association between polymorphisms in PRNCR1 and risk of colorectal cancer in the Saudi population [J].
AlMutairi, Mohammad ;
Parine, Narasimha Reddy ;
Shaik, Jilani Purusottapatnam L. ;
Aldhaian, Sooad ;
Azzam, Nahla A. ;
Aljebreen, Abdulrahman M. ;
Alharbi, Othman ;
Almadi, Majid A. ;
Al-Balbeesi, Amal O. ;
Alanazi, Mohammad .
PLOS ONE, 2019, 14 (09)
[3]   Downregulation of lncRNA AWPPH inhibits colon cancer cell proliferation by downregulating GLUT-1 [J].
Bai, Jie ;
Xu, Jian ;
Zhao, Jian ;
Zhang, Rui .
ONCOLOGY LETTERS, 2019, 18 (02) :2007-2012
[4]   Conditional loss of ERK1 and ERK2 results in abnormal placentation and delayed parturition in the mouse [J].
Brown, Jessica L. ;
Sones, Jennifer L. ;
Angulo, Cynthia N. ;
Abbott, Keelin ;
Miller, Andrew D. ;
Boehm, Ulrich ;
Roberson, Mark S. .
SCIENTIFIC REPORTS, 2019, 9 (1)
[5]   CLDN8 promotes colorectal cancer cell proliferation, migration, and invasion by activating MAPK/ERK signaling [J].
Cheng, Bo ;
Rong, Aimei ;
Zhou, Quanbo ;
Li, Wenlu .
CANCER MANAGEMENT AND RESEARCH, 2019, 11 :3741-3751
[6]   hsa_circRNA_0006528 as a competing endogenous RNA promotes human breast cancer progression by sponging miR-7-5p and activating the MAPK/ERK signaling pathway [J].
Gao, Danfeng ;
Qi, Xiaowei ;
Zhang, Xiufen ;
Fang, Kai ;
Guo, Zijian ;
Li, Lihua .
MOLECULAR CARCINOGENESIS, 2019, 58 (04) :554-564
[7]   Long non-coding RNA Linc00662 promotes cell invasion and contributes to cancer stem cell-like phenotypes in lung cancer cells [J].
Gong, Wenjing ;
Su, Yi ;
Liu, Yan ;
Sun, Ping ;
Wang, Xiumei .
JOURNAL OF BIOCHEMISTRY, 2018, 164 (06) :461-469
[8]   LncRNA CCAT1 promotes autophagy via regulating ATG7 by sponging miR-181 in hepatocellular carcinoma [J].
Guo, Jianbo ;
Ma, Yingbo ;
Peng, Xueqiang ;
Jin, Hongyuan ;
Liu, Jingang .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (10) :17975-17983
[9]   MicroRNA-98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k-Ras/Raf/MEK/ERK signaling pathway [J].
Guo, Long ;
Bai, Yu ;
Ji, Shuzhe ;
Ma, Hong .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (03) :807-820
[10]   Dehydrocorydaline inhibits cell proliferation, migration and invasion via suppressing MEK1/2-ERK1/2 cascade in melanoma [J].
Hu, Huanrong ;
Dong, Zhen ;
Wang, Xianxing ;
Bai, Longchang ;
Lei, Qian ;
Yang, Jie ;
Li, Lin ;
Li, Qian ;
Liu, Lichao ;
Zhang, Yanli ;
Ji, Yacong ;
Guo, Leiyang ;
Liu, Yaling ;
Cui, Hongjuan .
ONCOTARGETS AND THERAPY, 2019, 12 :5163-5175